Gene Editing

CRISPR Technology CRISPR Gene Therapy Therapeutic Applications Base Editing Research Crispr Technology CRISPR/Cas9 AI in Medicine CRISPR-Cas9

3 ARTICLES

last wk.

Major Research Centers Launch Nonprofit to Scale Gene‑Editing Treatments

The Center for Therapeutic Genetics will use ARPA‑H funding to build shared methods, safety data, manufacturing training to make precision genetic medicine repeatable, more affordable, easier to deliver.

7 ARTICLES

last mo.

Columbia Team Reports First Precise Base Edits in Human Embryos

3 ARTICLES

last mo.

China Team Performs First Combined Pig Liver and Both Kidneys Transplant Into Human

6 ARTICLES

2mo ago

Breakthrough T1D Backs CAR-Treg Beta-Cell Therapy as UChicago Reports PD‑L1 mRNA Results

10 ARTICLES

5mo ago

FDA Proposes ‘Plausible Mechanism’ Pathway for Individualized Rare-Disease Therapies

3 ARTICLES

5mo ago

Light-Based Sensor Detects Cancer Biomarkers in Blood at Sub-Attomolar Levels

3 ARTICLES

6mo ago

Oldham Teen Returns to Thank Nurse After Pioneering CRISPR Thalassaemia Treatment

5 ARTICLES

7mo ago

EU Strikes Provisional Deal to Ease Rules for Gene-Edited Crops

3 ARTICLES

8mo ago

CRISPR-Edited Fungus Boosts Mycoprotein Efficiency, Cuts Modeled Emissions

8 ARTICLES

8mo ago

India Unveils BIRSA 101, First Home-Grown CRISPR Therapy for Sickle Cell Disease

4 ARTICLES

8mo ago

FDA Outlines 'Plausible-Mechanism' Pathway to Speed Bespoke Therapies

3 ARTICLES

9mo ago

Intellia Pauses Phase 3 Trials of CRISPR Therapy After Severe Liver Event

6 ARTICLES

9mo ago

Lilly to Buy Adverum in Gene‑Therapy Deal Worth Up to $12.47 a Share

4 ARTICLES

9mo ago

Antibody Blocking SLAMF6 Restores T-Cell Attack on AML in Preclinical Study

8 ARTICLES

10mo ago

Nature Papers Identify RHOG and CDKN1B as In Vivo Boosters for CAR T Cells

6 ARTICLES

11mo ago

Kite Pharma to Buy Interius for $350 Million, Adding In‑Vivo CAR‑T Platform

3 ARTICLES

11mo ago

Kidney Organoids Reveal NFκB‑Linked AAV2 Toxicity, With Bardoxolone Methyl Mitigating Damage

Gene Editing

Major Research Centers Launch Nonprofit to Scale Gene‑Editing Treatments

Columbia Team Reports First Precise Base Edits in Human Embryos

China Team Performs First Combined Pig Liver and Both Kidneys Transplant Into Human

One Infusion Cuts LDL by Up to 62% in Early Gene‑Editing Trial

Single Infusion Gene Editing Lowers LDL by Up to 62% in Early Trial

CRISPR Enzyme Cas12a2 Selectively Destroys Cells Based on RNA in Lab Tests

Breakthrough T1D Backs CAR-Treg Beta-Cell Therapy as UChicago Reports PD‑L1 mRNA Results

FDA Proposes ‘Plausible Mechanism’ Pathway for Individualized Rare-Disease Therapies

Light-Based Sensor Detects Cancer Biomarkers in Blood at Sub-Attomolar Levels

Oldham Teen Returns to Thank Nurse After Pioneering CRISPR Thalassaemia Treatment

Never miss stories about

Gene Editing

EU Strikes Provisional Deal to Ease Rules for Gene-Edited Crops

CRISPR-Edited Fungus Boosts Mycoprotein Efficiency, Cuts Modeled Emissions

India Unveils BIRSA 101, First Home-Grown CRISPR Therapy for Sickle Cell Disease

FDA Outlines 'Plausible-Mechanism' Pathway to Speed Bespoke Therapies

Intellia Pauses Phase 3 Trials of CRISPR Therapy After Severe Liver Event

Lilly to Buy Adverum in Gene‑Therapy Deal Worth Up to $12.47 a Share

Antibody Blocking SLAMF6 Restores T-Cell Attack on AML in Preclinical Study

Nature Papers Identify RHOG and CDKN1B as In Vivo Boosters for CAR T Cells

Kite Pharma to Buy Interius for $350 Million, Adding In‑Vivo CAR‑T Platform

Kidney Organoids Reveal NFκB‑Linked AAV2 Toxicity, With Bardoxolone Methyl Mitigating Damage

Never miss stories about

Gene Editing